Cargando…

The expression of vasohibin-1 and its prognostic significance in bladder cancer

Angiogenesis is important in the development of solid tumors. Vasohibin-1 (VASH-1) is an endothelium-derived protein that acts as an inhibitor of angiogenesis in many different types of cancer. However, the expression of VASH-1 and its clinical value in bladder cancer remain unknown. The current stu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bo, Wu, Zhouliang, Xie, Wanqin, Tian, Dawei, Chen, Feiran, Qin, Chuan, Du, Zhiyong, Tang, Gang, Gao, Qiongqiong, Qiu, Xiaoyu, Wu, Changli, Tian, Jing, Hu, Hailong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639433/ https://www.ncbi.nlm.nih.gov/pubmed/29042936 http://dx.doi.org/10.3892/etm.2017.4969

Ejemplares similares

Preoperative hemoglobin-platelet ratio can significantly predict progression and mortality outcomes in patients with T1G3 bladder cancer undergoing transurethral resection of bladder tumor
por: Tang, Gang, et al.
Publicado: (2018)

AB262. Expression of vasohibin-1 in prostate cancer and its progress research
por: Zhang, Bo, et al.
Publicado: (2016)

AB175. Girdin protein is a novel prognosis predictor for patients with non-muscle invasive bladder cancer
por: Wu, Zhouliang, et al.
Publicado: (2016)

The prognostic significance of vasohibin-1 expression in patients with prostate cancer
por: Kosaka, T, et al.
Publicado: (2013)

The comparison of perioperative outcomes of robot-assisted and open partial nephrectomy: a systematic review and meta-analysis
por: Shen, Zhonghua, et al.
Publicado: (2016)

Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

AB058. Intravenous chemotherapy combined with intravesical chemotherapy to treat T1G3 bladder urothelial carcinoma after transurethral resection of bladder tumor: results of a retrospective study
por: Zhang, Yu, et al.
Publicado: (2016)

AB112. Expression of brain-specific angiogenesis inhibitor 1 and association with p53, microvessel density and vascular endothelial growth factor in the tissue of human bladder transitional cell carcinoma
por: Tian, Dawei, et al.
Publicado: (2016)

The Vasohibin Family
por: Sato, Yasufumi
Publicado: (2010)

AB111. Genetic variations rs11892031 and rs401681 are associated with bladder cancer risk in a Chinese population
por: Zhang, Yu, et al.
Publicado: (2016)

AB176. Impact of squamous and/or glandular differentiation on recurrence and progression after transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2016)

Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patients
por: Shen, Chong, et al.
Publicado: (2020)

Impact of squamous and/or glandular differentiation on recurrence and progression following transurethral resection for non-muscle invasive urothelial carcinoma of bladder
por: Xu, Hao, et al.
Publicado: (2017)

Risk Factors Predictive of Recurrence and Progression for Patients Who Suffered Initial Recurrence After Transurethral Resection of Stage pT1 Bladder Tumor in Chinese Population: A Retrospective Study
por: Shen, Zhonghua, et al.
Publicado: (2016)

AB265. Association between MDM2 SNP309T>G polymorphism and the risk of bladder cancer: new data in Chinese population and an update meta-analysis
por: Xie, Linguo, et al.
Publicado: (2016)

The roles of vasohibin and its family members: Beyond angiogenesis modulators
por: Du, Hua, et al.
Publicado: (2017)

The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

Vasohibin-1 suppresses colon cancer
por: Liu, Shuai, et al.
Publicado: (2015)

Structural basis of tubulin detyrosination by vasohibins
por: Li, Faxiang, et al.
Publicado: (2019)

Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer
por: Shen, Chong, et al.
Publicado: (2020)

Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2015)

Structural insights into tubulin detyrosination by vasohibins-SVBP complex
por: Liu, Xi, et al.
Publicado: (2019)

Enhanced Cancer Metastasis in Mice Deficient in Vasohibin-1 Gene
por: Ito, Soichi, et al.
Publicado: (2013)

Exacerbation of Diabetic Renal Alterations in Mice Lacking Vasohibin-1
por: Hinamoto, Norikazu, et al.
Publicado: (2014)

Role of the Vasohibin Family in the Regulation of Fetoplacental Vascularization and Syncytiotrophoblast Formation
por: Suenaga, Kaori, et al.
Publicado: (2014)

Age‐associated downregulation of vasohibin‐1 in vascular endothelial cells
por: Takeda, Eichi, et al.
Publicado: (2016)

AB188. Vasohibin-1 and microvessel density predict prognosis in clear cell renal cell carcinoma
por: Tian, Hao, et al.
Publicado: (2016)

Mechanism of ELL-associated factor 2 and vasohibin 1 regulating invasion, migration, and angiogenesis in colorectal cancer
por: Feng, Ming-Liang, et al.
Publicado: (2023)

Metastasis-Associated in Colon Cancer 1 Is a Novel Survival-Related Biomarker for Human Patients with Renal Pelvis Carcinoma
por: Hu, Hailong, et al.
Publicado: (2014)

Double-Face of Vasohibin-1 for the Maintenance of Vascular Homeostasis and Healthy Longevity
por: Sato, Yasufumi
Publicado: (2018)

Vasohibin‐2 plays an essential role in metastasis of pancreatic ductal adenocarcinoma
por: Iida‐Norita, Rie, et al.
Publicado: (2019)

Vasohibin 1 selectively regulates secondary sprouting and lymphangiogenesis in the zebrafish trunk
por: de Oliveira, Marta Bastos, et al.
Publicado: (2021)

Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature
por: da Silva, Daniel de Castilho, et al.
Publicado: (2022)

AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)

AB266. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer
por: Chen, Tao, et al.
Publicado: (2016)

Prognostic significance of urothelial carcinoma with divergent differentiation in upper urinary tract after radical nephroureterectomy without metastatic diseases: A retrospective cohort study
por: Qin, Chuan, et al.
Publicado: (2017)

Genetic Variations rs11892031 and rs401681 Are Associated with Bladder Cancer Risk in a Chinese Population
por: Zhang, Yu, et al.
Publicado: (2014)

AB182. The value of extensive transurethral resection in the diagnosis and treatment of non-muscle invasive bladder cancer with respect to the recurrence at the first follow-up cystoscopy
por: Qie, Yunkai, et al.
Publicado: (2016)

Novel strategy of liver cancer treatment with modified antisense oligonucleotides targeting human vasohibin‐2
por: Horie, Sachiko, et al.
Publicado: (2023)

Vasohibin inhibits angiogenic sprouting in vitro and supports vascular maturation processes in vivo
por: Kern, Johann, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_v6okrdqm7apot5nbi52lc5arou